Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy

BACKGROUND: Miltefosine, which is the first oral drug licensed for the treatment of leishmaniasis, was recently reported to be a promising lead compound for the synthesis of novel antischistosomal derivatives with potent activity in vivo against different developmental stages of Schistosoma mansoni....

Full description

Saved in:
Bibliographic Details
Main Authors: Eissa, Maha M, El Bardicy, Samia, Tadros, Menerva
Format: Artigo
Language:Inglês
Published: BioMed Central 2011
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114006/
https://ncbi.nlm.nih.gov/pubmed/21569375
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-3305-4-73
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items